Editorial Epublish 11 citations
PubMed: 38256040 DOI: 10.3390/ijms25020967
Neurodegenerative Disease: From Molecular Basis to Therapy.
Int J Mol Sci 25(2)
Authors: Claudia Ricci
Affiliations
- Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.
Abstract
Neurodegenerative diseases are a heterogeneous group of age-related disorders characterised by the progressive degeneration or death of neurons in the central or peripheral nervous system [...].
MeSH
Therapeutics, Neurodegenerative Diseases
Cited by
- Hydrogen Sulfide and Gut Microbiota: Their Synergistic Role in Modulating Sirtuin Activity and Potential Therapeutic Implications for Neurodegenerative Diseases. Pharmaceuticals (Basel), 2024
- The rise of 3D bioprinting advancements in modeling neurodegenerative diseases. Ibrain, 2025
- Association of Helicobacter pylori infection with the risk of neurodegenerative disorders: a systematic review and meta-analysis. Front Med (Lausanne), 2025
- Mitochondrial quality control disorder in neurodegenerative disorders: Potential and advantages of traditional Chinese medicines. J Pharm Anal, 2025
- Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine. Planta Med, 2025
- Nerve growth factor: what can surgeons and oncologists learn from a neurological and psychological biomarker? Mol Med, 2025